These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy. Zhou J; Wang S; Xia X Curr Eye Res; 2012 May; 37(5):416-20. PubMed ID: 22409294 [TBL] [Abstract][Full Text] [Related]
3. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy. Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136 [TBL] [Abstract][Full Text] [Related]
4. Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy. Wakabayashi Y; Usui Y; Okunuki Y; Ueda S; Kimura K; Muramatsu D; Kezuka T; Goto H Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6403-10. PubMed ID: 22899753 [TBL] [Abstract][Full Text] [Related]
5. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy. Mohan N; Monickaraj F; Balasubramanyam M; Rema M; Mohan V J Diabetes Complications; 2012; 26(5):435-41. PubMed ID: 22699109 [TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy. Sydorova M; Lee MS Ophthalmic Res; 2005; 37(4):188-90. PubMed ID: 15990461 [TBL] [Abstract][Full Text] [Related]
7. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease. Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597 [TBL] [Abstract][Full Text] [Related]
8. Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines. Schoenberger SD; Kim SJ; Sheng J; Rezaei KA; Lalezary M; Cherney E Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5906-11. PubMed ID: 22871833 [TBL] [Abstract][Full Text] [Related]
9. Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy. Chernykh VV; Varvarinsky EV; Smirnov EV; Chernykh DV; Trunov AN Indian J Ophthalmol; 2015 Jan; 63(1):33-6. PubMed ID: 25686060 [TBL] [Abstract][Full Text] [Related]
10. Identification of chemokines and growth factors in proliferative diabetic retinopathy vitreous. Dai Y; Wu Z; Wang F; Zhang Z; Yu M Biomed Res Int; 2014; 2014():486386. PubMed ID: 25401103 [TBL] [Abstract][Full Text] [Related]
11. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy. Wang Y; Gao S; Zhu Y; Shen X Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987 [TBL] [Abstract][Full Text] [Related]
12. Level of Vascular Endothelial Growth Factor in the Vitreous Fluid of Proliferative Diabetic Retinopathy Patients and Prognosis after Vitrectomy. Suzuki Y; Suzuki K; Kudo T; Metoki T; Nakazawa M Ophthalmologica; 2016; 236(3):133-138. PubMed ID: 27794575 [TBL] [Abstract][Full Text] [Related]
13. Risk evaluation of outcome of vitreous surgery based on vitreous levels of cytokines. Funatsu H; Yamashita H; Mimura T; Noma H; Nakamura S; Hori S Eye (Lond); 2007 Mar; 21(3):377-82. PubMed ID: 16410812 [TBL] [Abstract][Full Text] [Related]
14. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056 [TBL] [Abstract][Full Text] [Related]
15. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635 [TBL] [Abstract][Full Text] [Related]
16. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles. Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700 [TBL] [Abstract][Full Text] [Related]
17. Effect of intravitreal bevacizumab on serum, aqueous, and vitreous humor levels of erythropoietin in patients with proliferative diabetic retinopathy. Cancarini A; Costagliola C; Dell'omo R; Romano M; Morescalchi F; Agnifili L; Ruggeri G; Semeraro F Minerva Endocrinol; 2014 Dec; 39(4):305-11. PubMed ID: 25371057 [TBL] [Abstract][Full Text] [Related]
18. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy. Itakura H; Kishi S; Kotajima N; Murakami M Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550 [TBL] [Abstract][Full Text] [Related]
19. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy. Wang X; Wang G; Wang Y Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381 [TBL] [Abstract][Full Text] [Related]
20. Increased sCD200 Levels in Vitreous of Patients With Proliferative Diabetic Retinopathy and Its Correlation With VEGF and Proinflammatory Cytokines. Xu Y; Cheng Q; Yang B; Yu S; Xu F; Lu L; Liang X Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6565-72. PubMed ID: 26457542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]